TY - JOUR
T1 - Clinical Course of a Unique Case of Allgrove Syndrome and Challenges of Hypoglycemia Management
AU - Lu, Chang
AU - Lee, Ting A.
AU - Pan, Debra H.
AU - Pereira, Elaine M.
AU - Zhou, Ping
N1 - Funding Information:
We thank Drs. Louise A. Metherell and Adrian J. L. Clark at the Molecular Endocrinology Laboratory in the Department of Endocrinology at Barts and The London School of Medicine and Dentistry for conducting the genetic testing which was crucial to the diagnosis of this patient.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Objective: Allgrove syndrome (AS), also known as triple-A syndrome, is a rare disorder characterized by alacrima, achalasia, adrenal insufficiency, and other manifestations such as problems related to growth, puberty, and neuropsychological development. Although the genetics of this disorder have been studied extensively in recent decades, clinical information is still lacking. Methods: We present a unique case of AS from which we have gained significant insight into its clinical course, especially the management of hypoglycemia. Results: The patient initially presented with altered mental status at age 3 which was found to be due to hypoglycemia. Laboratory values confirmed primary adrenal insufficiency with isolated glucocorticoid deficiency. With additional history of alacrima, a genetic test was obtained which confirmed the diagnosis of AS. For over 10 years, we have been following her growth, puberty, and development. We experienced some challenges in managing her hypoglycemia initially. Certain metabolic effects of steroid overdose were noted. To resolve this problem, we found dextrose supplementation quite effective. Conclusion: The rarity and isolated glucocorticoid deficiency of AS pose clinical challenges for initial diagnosis. Hypoglycemia associated with alacrima should alert the suspicion of AS. Management of hypoglycemia in AS is complicated by achalasia and may benefit from incorporation of both glucocorticoid and dextrose supplementation to prevent side effects of steroid overdose.
AB - Objective: Allgrove syndrome (AS), also known as triple-A syndrome, is a rare disorder characterized by alacrima, achalasia, adrenal insufficiency, and other manifestations such as problems related to growth, puberty, and neuropsychological development. Although the genetics of this disorder have been studied extensively in recent decades, clinical information is still lacking. Methods: We present a unique case of AS from which we have gained significant insight into its clinical course, especially the management of hypoglycemia. Results: The patient initially presented with altered mental status at age 3 which was found to be due to hypoglycemia. Laboratory values confirmed primary adrenal insufficiency with isolated glucocorticoid deficiency. With additional history of alacrima, a genetic test was obtained which confirmed the diagnosis of AS. For over 10 years, we have been following her growth, puberty, and development. We experienced some challenges in managing her hypoglycemia initially. Certain metabolic effects of steroid overdose were noted. To resolve this problem, we found dextrose supplementation quite effective. Conclusion: The rarity and isolated glucocorticoid deficiency of AS pose clinical challenges for initial diagnosis. Hypoglycemia associated with alacrima should alert the suspicion of AS. Management of hypoglycemia in AS is complicated by achalasia and may benefit from incorporation of both glucocorticoid and dextrose supplementation to prevent side effects of steroid overdose.
UR - http://www.scopus.com/inward/record.url?scp=85124185926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124185926&partnerID=8YFLogxK
U2 - 10.4158/ACCR-2019-0210
DO - 10.4158/ACCR-2019-0210
M3 - Article
AN - SCOPUS:85124185926
SN - 2376-0605
VL - 5
SP - e357-e361
JO - AACE Clinical Case Reports
JF - AACE Clinical Case Reports
IS - 6
ER -